Cryopreserved Platelets (CPP) for US FDA Licensure

Agency: DEPT OF DEFENSE
State: Maryland
Type of Government: Federal
FSC Category:
  • A - Research and development
NAICS Category:
  • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Posted Date: Apr 23, 2026
Due Date: May 4, 2026
Solicitation No: HT9427-26-RFI-705
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Cryopreserved Platelets (CPP) for US FDA Licensure
Active
Contract Opportunity
Notice ID
HT9427-26-RFI-705
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE HEALTH AGENCY (DHA)
Office
ARMY MED RES ACQ ACTIVITY
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Sources Sought (Original)
  • Original Published Date: Apr 23, 2026 12:47 pm EDT
  • Original Response Date: May 04, 2026 03:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: May 19, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    Frederick , MD 21702
    USA
Description

Defense Health Agency seeks to develop and manage medical materiel to protect and sustain the Warfighter on point for the Nation. We develop, directly through collaboration with commercial partners, medical products that enhance readiness and improve the quality of life of active-duty personnel in the operational environment. OPMED’s WPAC PMO has been developing a biologic product: Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), a frozen, biologic-platelet product. DMSO CPP are formulated to provide a platelet-derived product with a longer shelf life (2 years and potentially longer) than liquid stored platelets (LSP), which are currently licensed for storage up to 5-7 days at room temperature (20ºC to 24ºC) under gentle agitation.


Attachments/Links
Contact Information
Contracting Office Address
  • 808 SCHREIDER ST
  • FORT DETRICK , MD 21702
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Apr 23, 2026 12:47 pm EDTSources Sought (Original)

Related Document

Apr 28, 2026[Sources Sought (Updated)] Cryopreserved Platelets (CPP) for US FDA Licensure
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow Request for Information (RFI) on Identifying Basic Research Challenges to Accelerate United

ENERGY, DEPARTMENT OF

Due by 10/15/2026

Follow Broad Agency Announcement DEVCOM C5ISR ESI Active Contract Opportunity Notice ID Related

DEPT OF DEFENSE

Due by 10/31/2027

Follow Broad Agency Announcement DEVCOM C5ISR RTI Active Contract Opportunity Notice ID W56KGU23RRTID

DEPT OF DEFENSE

Due by 10/31/2027

Follow BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT

DEPT OF DEFENSE

Due by 6/11/2027

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.